Navigation Links
Hill-Rom Reports Fiscal Fourth Quarter and Full Year Results; Provides 2012 Financial Outlook

BATESVILLE, Ind., Oct. 26, 2011 /PRNewswire/ -- Hill-Rom Holdings, Inc. (NYSE: HRC), announced financial results for its fiscal fourth quarter ended September 30, 2011 and provided its outlook for 2012. Adjusted earnings per diluted share increased 7 percent during the period, to $0.72 from $0.67.  Reported earnings per diluted share in the fourth quarter increased to $1.01, compared to $0.79 in the same period in the prior year, and net income increased to $64 million from $51 million over the same period.  Reported net income includes a net after-tax gain of $18 million, primarily related to previously unrecognized tax benefits associated with international operating loss carryforwards, partially offset by legal settlement costs.  

Hill-Rom's quarterly revenue of $431 million increased 9 percent on a reported basis and 7 percent on a constant currency basis compared to last year.  Domestic revenue increased 12 percent to $309 million, while revenue outside the United States increased 2 percent to $122 million in the same period.  Excluding the impact of foreign currency, Hill-Rom's revenue outside the United States declined 4 percent.

For the full year, revenue was $1,592 million compared to $1,470 million for the prior year, an increase of 8 percent on a reported basis and 7 percent on a constant currency basis.  Adjusted earnings per diluted share for fiscal 2011 were $2.27 compared to $1.76 in 2010, an increase of 29 percent.  Reported earnings per diluted share for the full year were $2.09 compared to $1.97 for the prior year, an increase of 6 percent.

Management Comments"We completed the year with strong revenue performance in the fourth quarter as continued growth in our North America Acute Care business more than offset weaker international results," stated John J. Greisch, President & CEO.  "This quarter concludes a year of increased revenue growth, margin expansion, solid earnings improvement and significant cash flow generation.   As we look forward to fiscal year 2012, we anticipate an increasingly challenging economic and healthcare environment.  However, we remain committed to revenue and earnings growth consistent with our long range plan objectives."

Financial and Operational Highlights

  • Fourth quarter revenue highlights include:
  • North America Acute Care.  North America Acute Care revenue grew 15 percent to $273 million.  Capital sales increased 21 percent due primarily to higher sales of patient support systems, which grew 30 percent.  Rental revenue declined 2 percent versus the prior year.
  • International.  International segment revenue, which excludes Canada, declined 2 percent to $105 million.  On a constant currency basis, revenue decreased 8 percent, as European sales growth was more than offset by sales declines in the Middle East and Asia-Pacific regions.
  • North America Post-Acute Care.  North America Post-Acute Care revenue increased 2 percent to $53 million.  Capital sales increased 5 percent and rental revenue increased 1 percent versus the prior year.  Both respiratory care and home care revenue grew while extended care revenue was flat to the prior year.
  • Full year operating cash flow was $223 million, compared to $140 million in the prior year, an increase of 59 percent.  Fiscal year 2011 operating cash flow includes outflows of $47 million for legal settlements.
  • Adjusted operating margin for the quarter decreased 50 basis points to 15.9 percent and for the full year increased 100 basis points to 13.5 percent.  
  • The Company received Food and Drug Administration (FDA) marketing clearance via the 510-k process for a powered stretcher product which we expect to commercialize in the first quarter of fiscal 2012.  
  • During the quarter, the Company completed the acquisition of Liko distributors in France and Switzerland for approximately $20 million.

  • Please see the attached schedules for additional information, including condensed financial information, summary balance sheet, cash flow statement and segment sales summaries.  

    For a more complete review of Hill-Rom's results, please refer to our Annual Report on Form 10-K for the year ended September 30, 2011, which will be filed in November.

    Financial Guidance Summary for 2012Financial guidance for fiscal 2012 is as follows:  Hill-Rom expects full-year constant currency revenue growth of between 4 and 5 percent.  The Company expects adjusted earnings guidance of $2.45 to $2.55 per diluted share.  Cash flow from operations for the full year is expected to be approximately $290 to $300 million.

    Hill-Rom Holdings, Inc. routinely provides earnings per share results and guidance on an adjusted basis because the Company's management believes that the presentation provides useful information to investors.  These measures exclude strategic developments, special charges and the impact of significant litigation or other unusual events. Such items may be highly variable, difficult to predict and of a size that sometimes have substantial impact on the Company's reported operations for a period. Often, prospective quantification of such items is not feasible.  Management uses these measures internally for planning, forecasting and evaluating the performance of the business. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

    Additional assumptions and discussion will be provided during the Company's conference call to be held tomorrow morning.  Information to access the webcast is provided below.

    Conference Call Webcast and Replay The Company will sponsor a conference call and webcast for the investing public at 8:00 a.m. ET, on Thursday, October 27, 2011.  The webcast is available at or and will be archived on the Company's website for those who are unable to listen live. A replay of the call is also available through November 4, 2011 at 855-859-2056 (404-537-3406 International). Code 12399914 is needed to access the replay.

    ABOUT HILL-ROM HOLDINGS, INC. Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals and information technology solutions.  Hill-Rom's comprehensive product and service offerings are used by health care providers across the health care continuum and around the world in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

    Hill-Rom...enhancing outcomes for patients and their caregivers.

    DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS Certain statements in this press release contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company's future plans, objectives, beliefs, expectations, representations and projections.  The Company has tried, wherever possible, to identify these forward-looking statements using words such as "intend," "anticipate," "believe," "plan," "encourage," "expect," "may," "goal," "become," "pursue," "estimate," "strategy," "will," "projection," "forecast," "continue," "accelerate," "promise," "increase," "higher," "lower," "reduce," "improve," "expand," "progress," "potential" or the negative of those terms or other variations of them or by comparable terminology.  The absence of such terms, however, does not mean that the statement is not forward-looking.  It is important to note that forward-looking statements are not guarantees of future performance, and the Company's actual results could differ materially from those set forth in any forward-looking statements.  Factors that could cause actual results to differ from forward-looking statements include but are not limited to: the Company's dependence on its relationships with several large group purchasing organizations, whether the Company's new products are successful in the marketplace, impacts of healthcare reform, compliance with federal healthcare programs, collections of accounts receivable, compliance with FDA regulations, antitrust and other litigation, potential exposure to product liability or other claims, failure of the Company's announced or future strategic initiatives and restructuring and realignment activities to achieve expected growth, efficiencies or cost reductions, adverse consequences resulting from the spin-off of the funeral services business, failure of the Company to execute its acquisition and business alliance strategy through the consummation and successful integration of acquisitions or entry into joint ventures or other business alliances, increased costs or unavailability of raw materials, adverse changes in global economic conditions or disruptions of credit markets, labor disruptions, the ability to retain executive officers and other key personnel, and certain tax-related matters.  For a more in depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in the Company's previously filed most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q.  The Company assumes no obligation to update or revise any forward-looking statements.Hill-Rom Holdings, Inc. and SubsidiariesCondensed Consolidated Statements of Income(Dollars in millions except per share data)Quarterly Period Ended September 30Year Ended September 302011201020112010Net revenuesCapital sales$
    996.6Rental revenues114.3114.0472.7473.0Total revenues430.6396.61,591.71,469.6Cost of revenuesCost of goods sold170.8151.2606.8548.6Rental expenses49.249.4203.6204.4Total cost of revenues220.0200.6810.4753.0Gross profitCapital145.5131.4512.2448.0Rental65.164.6269.1268.6Total gross profit210.6196.0781.3716.6As a percentage of sales48.9%49.4%49.1%48.8%Research and development expenses15.514.963.858.3Selling and administrative expenses126.9116.0502.0474.6Litigation charge (credit)5.0(21.2)47.3(21.2)Special charges-8.21.413.2Operating profit63.278.1166.8191.7Other income (expense), net(2.6)(3.9)(7.1)(8.8)Income tax (benefit) expense(2.9)23.426.256.9Net income 63.550.8133.5126.0Less:  Net income attributable to noncontrolling interest- income attributable to common shareholders$
    25.3Diluted earnings per share:$
    .97Average common shares outstanding - diluted
    (thousands)63,11764,32863,89963,739Dividends per common share$
    .41Non-GAAP Financial Disclosures and ReconciliationsWhile Hill-Rom reports financial results in accordance with U.S. GAAP, this press release includes non-GAAP measures. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Hill-Rom uses the non-GAAP measures to evaluate and manage its operations and provides the information to assist investors in performing financial analysis that is consistent with financial models developed by research analysts. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

    Hill-Rom Holdings, Inc. and SubsidiariesRevenues - Constant Currency(Dollars in millions)Quarterly Period Ended September 302011Foreign Exchange 20112010Constant CurrencyAs ReportedImpactAdjustedAs ReportedChangeCapital sales$
    282.69.9%Rental revenues114.31.3113.0114.0-0.9%Total$
    396.66.8%Acute Care$
    237.614.4%Post-Acute Care53.0- 105.16.398.8106.9-7.6%Total $
    396.66.8%Year Ended September 302011Foreign Exchange20112010Constant CurrencyAs ReportedImpactAdjustedAs ReportedChangeCapital sales$
    996.610.8%Rental revenues472.72.5470.2473.0-0.6%Total$
    ,469.67.2%Acute Care$
    875.811.6%Post-Acute Care209.1-209.1205.71.7%International 401.613.2388.4388.10.1%Total $
    ,469.67.2%Hill-Rom Holdings, Inc. and SubsidiariesReconciliation: Earnings Per Share(Dollars in millions except per share data)Quarterly Period Ended September 30, 2011Quarterly Period Ended September 30, 2010Income Before

    Income TaxesIncome Tax
    ExpenseDiluted EPSIncome Before
    Income Taxes
    and NCIIncome Tax
    Expense*Diluted EPSGAAP Earnings$
    .79Adjustments:Litigation charge (credit) product recall(0.9)(0.4)(0.01)---Special charges-(0.2)- and integration costs1.00.40.01---Recognition of previously unrecognized tax attributes-21.5(0.34)---Adjusted Earnings$
    .67Year Ended September 30, 2011Year Ended September 30, 2010Income Before

    Income Taxes
    and NCI*Income Tax
    Expense*Diluted EPSIncome Before
    Income Taxes
    and NCIIncome Tax
    ExpenseDiluted EPS*GAAP Earnings $
    .97Adjustments:Litigation charge (credit)47.314.20.52(21.2)(8.3)(0.20)Vendor product recall(2.3)(0.9)(0.02)---Special charges1.40.50.0113.25.00.13Acquisition and integration costs1.00.40.01---Recognition of previously unrecognized tax attributes-21.5(0.34)---Gain on sale of non-strategic assets----1.7(0.03)Tax settlement----6.5(0.10)Adjusted Earnings$
    .76* May not add due to rounding.Hill-Rom Holdings, Inc. and SubsidiariesCondensed Consolidated Balance Sheets(Dollars in millions)September 30, 2011September 30, 2010AssetsCurrent AssetsCash and cash equivalents$
    84.5Trade accounts receivable, net of allowances386.2353.1Inventories, net95.6108.5Other current assets85.393.1Total current assets791.7739.2Property, plant and equipment, net222.8243.7Goodwill87.281.1Other assets197.4181.6Total Assets$
    ,245.6LiabilitiesCurrent LiabilitiesTrade accounts payable$
    80.6Short-term borrowings100.353.1Other current liabilities168.9155.0Total current liabilities334.0288.7Long-term debt50.898.5Other long-term liabilities172.6142.6Total Liabilities557.4529.8Noncontrolling interest-8.3Shareholders' Equity741.7707.5Total Liabilities, Noncontrolling Interest and Shareholders' Equity$
    ,245.6Hill-Rom Holdings, Inc. and SubsidiariesConsolidated Statements of Cash Flows(Dollars in millions) Year Ended September 30 2011 2010 Operating ActivitiesNet income $
    26.0Adjustments to reconcile net income to net cash provided by   operating activities:Depreciation and amortization103.999.7Provision for deferred income taxes(21.5)21.2Loss on disposal of property, equipment leased to others,intangible assets and impairments1.37.3Stock compensation12.212.0Excess tax benefits from employee stock plans(6.8)-IRS tax settlement(4.9)(8.2)Litigation credit-(21.2)Defined benefit plan funding(1.4)(52.3)Change in working capital excluding cash, current investments,current debt and acquisitions and dispositions:Trade accounts receivable(24.7)(7.0)Inventories14.7(16.2)Other current assets14.4(37.5)Trade accounts payable(18.0)(2.4)Accrued expenses and other liabilities10.012.5Other, net9.85.9Net cash provided by operating activities222.5139.8Investing ActivitiesCapital expenditures and purchase of intangibles(68.9)(64.7)Proceeds on sales of property and equipment leased to others5.92.5Acquisitions of businesses, net of cash acquired(15.5)(7.3)Proceeds on investment sales/maturities0.531.3Net cash used in investing activities(78.0)(38.2)Financing ActivitiesChange in short-term debt(0.4)(4.1)Payment on revolver(0.2)(45.0)Purchase of noncontrolling interest(11.8)-Distribution to noncontrolling interest partner-(1.1)Payment of cash dividends(27.0)(25.8)Proceeds on exercise of options43.122.9Proceeds from stock issuance2.92.6Excess tax benefits from employee stock plans6.8-Treasury stock acquired(115.3)(36.9)Net cash used in financing activities(101.9)(87.4)Effect of exchange rate changes on cash(2.5)(0.3)Total Cash Flows40.113.9Cash and Cash Equivalents:At beginning of period184.5170.6At end of period$

    SOURCE Hill-Rom Holdings, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Hill-Rom Announces Appointment of James R. Giertz to Board of Directors
    2. Hill-Rom Announces Corporate Governance Enhancements
    3. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Fourth Quarter Earnings and 2010 Financial Guidance Webcast
    4. Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter
    5. Hill-Rom and Encompass Group Form Joint Venture
    6. Hill-Rom to Host Investors Conference in New York City
    7. Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies
    8. Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings
    9. Hill-Rom Introduces Smart Bed Technology into CareAssist(R) ES Bed
    10. Hill-Rom to Present at the Canaccord Adams Musculoskeletal Conference
    11. Hill-Rom Extends Smart Bed Features for High-Tech Hospital Rooms
    Post Your Comments:
    (Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
    (Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
    (Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
    Breaking Medicine Technology:
    (Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... As health ... medicine known as “patient engagement.” The patient is doing more than filling out a ... , “There is an increasing emphasis in health care and research on the ...
    (Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
    (Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a ... utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the ... a CBD form that can be easily incorporated into liquid products, while reducing costs ...
    (Date:10/13/2017)... ... 2017 , ... Lori R. Somekh, founder of the Law Office of ... elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain ... to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
    (Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
    Breaking Medicine News(10 mins):